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 ■ Abstract 
BACKGROUND: Bilberries and blackcurrants are nutrient 
sources rich in bioactive components, including dietary fi-
bers, polyphenols, and anthocyanins, which possess potent 
cardiovascular protective properties. Few studies investigat-
ing the cardio-protective effects of natural components have 
focused on whole bilberries or blackcurrants. OBJECTIVE: 
The aim of this trial was to investigate whether a diet en-
riched with bilberries or blackcurrants has beneficial effects 
on glucose metabolism, lipid profile, blood pressure, and 
expression of genes related to glucose and lipid metabolism. 
METHODS: Male Zucker Diabetic Fatty (ZDF) rats (n = 48) 
were randomly assigned to either a control, bilberry-
enriched, blackcurrant-enriched, or fiber-enriched diet for 8 
weeks ad libitum. Real-time quantitative PCR analysis was 
performed on liver, adipose, and muscle tissue. Berry poly-
phenol content was determined by HPLC and LC-MS analy-
sis. RESULTS: Bilberry enrichment reduced total (-21%, p = 
0.0132) and LDL-cholesterol (-60%, p = 0.0229) levels, but 
increased HDL-cholesterol to a lesser extent than in con-
trols. This may partly be due to the altered hepatic liver X 
receptor-α expression (-24%, p < 0.001). Neither bilberries 
nor blackcurrants influenced glucose metabolism or blood 
pressure. Nevertheless, transcriptional analysis implied a 
better conservation of hepatic and adipocyte insulin sensitiv-
ity by bilberry enrichment. Anthocyanins constituted 91% 
and 87% of total polyphenol content in bilberries and black-
currants, respectively. However, total anthocyanin content 
(3441 mg/100 g) was 4-fold higher in bilberries than in 
blackcurrants (871 mg/100 g). CONCLUSIONS: Bilberry 
consumption ameliorated total and LDL-cholesterol levels, 
but not HDL-cholesterol levels in ZDF rats. Neither bilberry 
nor blackcurrant enrichment delayed the development of 
diabetes or hypertension. Thus, in rats, bilberries may be 
valuable as a dietary preventive agent against hypercholes-
terolemia, probably by virtue of their high anthocyanin con-
tent. 
 
 
Keywords: bilberry · blackcurrant · anthocyanins · choles-
terol · insulin sensitivity · blood pressure · type 2 diabetes · 
obesity  
 
Introduction 
 
 entral obesity and metabolic diseases such as 
 insulin resistance, dyslipidemia, low-grade 
 chronic inflammation, endothelial dysfunc-
tion, and hypertension are all conditions that 
commonly precede the development of type 2 dia-
betes (T2D) and cardiovascular disease (CVD). 
CVD remains one of the leading causes of death, 
and is therefore a primary focus of research and 
treatment [1]. Fortunately, several CVD risk fac-
tors are preventable and treatable. 
Mounting evidence from epidemiological studies 
indicates that the consumption of diets rich in 
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fruits and vegetables is associated with an im-
proved cardiovascular risk profile [2]. Several 
components of fruit and vegetables may exert 
cardio-protective effects, including dietary fibers, 
micronutrients, and polyphenols [3, 4]. Antho-
cyanins and flavonols constitute a subclass of 
polyphenols that possesses a wide range of potent 
disease-protective properties [5]. Bilberries (vac-
cinuim myrtillus) and blackcurrants (ribes nigrum) 
are food sources that are particularly rich in 
bioavailable anthocyanins and flavonols [6, 7]. 
Moreover, the relative antioxidant activity of an-
thocyanins and flavonols in bilberries and black-
currants is especially high [8] and several studies 
have demonstrated beneficial effects of these ber-
ries on antioxidant status and low-grade inflam-
mation [9-12]. 
Although several studies have investigated the 
CVD-related effects of anthocyanins and antho-
cyanin-rich berry extracts or juices, only few stud-
ies have focused on the effects of whole bilberries 
or blackcurrants per se. In subjects with increased 
CVD risk, consumption of bilberries and blackcur-
rants (100 g/day) together with juice/nectar from 
other berries (approximately 50 g/day) for 8 weeks 
resulted in favorable changes in platelet function, 
HDL-cholesterol, and blood pressure [13]. An ex-
tract of mixed anthocyanins from bilberries and 
blackcurrants given to dyslipidemic Chinese sub-
jects for 12 weeks improved LDL- and HDL-
cholesterol [14]. In animal studies, anthocyanin-
rich bilberry extracts have been shown to amelio-
rate atherosclerosis in Apo-E deficient mice [15], 
and hyperglycemia and insulin sensitivity in dia-
betic mice [16]. 
The primary aim of this study was to investi-
gate whether a diet rich in bilberries or blackcur-
rants has favorable effects on glucose metabolism 
and is able to delay the progression to T2D in 
Zucker Diabetic Fatty (ZDF) rats. Concomitantly, 
we examined the effects on lipid profile and blood 
pressure. In addition, the underlying mechanisms 
of action were explored by focusing on the expres-
sion of genes related to glucose and lipid metabo-
lism in insulin-sensitive tissues. 
Materials and methods 
Animals and experimental design 
Forty-eight male ZDF (Crl-Leprfa) rats were ob-
tained from Charles River Laboratories in Ger-
many. The homozygous recessive ZDF rat is an 
experimental inbred model that mimics the meta- 
 
bolic abnormalities of T2D and its cardiovascular 
complications, including dyslipidemia [17]. When 
fed a high-carbohydrate diet, T2D develops at ap-
proximately 12 weeks of age [18]. The animals 
were caged individually in enclosed ventilated 
cabinets controlled for temperature (22 °C), rela-
tive humidity (50%), and light conditions (12 hour 
light/dark cycles). Before entering the experiment, 
animals were acclimated for 5 days and fed a 
standard chow diet ad libitum (Altromin 1324, 
Brogaarden, Denmark). 
At 7 weeks of age, the animals were randomly 
divided into 4 different diet groups (n = 12/group), 
and then observed for 8 weeks. At baseline, an oral 
glucose tolerance test (OGTT) was performed, and 
overnight-fasting blood samples for biochemical 
analysis were obtained. Blood samples were col-
lected from the tip of the tail in chilled tubes con-
taining heparin/aprotinin. Subsequently, the sam-
ples were centrifuged. Plasma was frozen for 
analysis of fasting insulin, glucose, triacylglycerol, 
free fatty acids (FFA), total cholesterol, and LDL- 
and HDL-cholesterol levels. Whole blood was col-
lected in tubes with tripotassium EDTA and frozen 
afterwards for the determination of glycosylated 
hemoglobin (HbA1c). 
Abbreviations: 
 
Adipor1 - adiponectin receptor 1 
Akt2 - serine/threonine-protein kinase 2 
ANOVA - analysis of variance 
CV - capillary voltage 
CVD - cardiovascular disease 
FABP4 - fatty acid binding protein 4 
FFA - free fatty acids 
GFAT - glutamine fructose-6-phosphate aminotransferase 
GLUT - glucose transporter 
HbA1c - glycosylated hemoglobin 
HDL - high density lipoprotein 
HOMA-β - homeostasis model assessment of β-cell function 
HOMA-IR, homeostasis model assessment of insulin resis-
tance 
HPLC - high-performance liquid chromatography 
iAUC - incremental area under the curve 
InsR - insulin receptor 
IRS - insulin receptor substrate 
JNK-1 - c-Jun N-terminal protein kinase 
LC-PDA-APCI-MS/MS - liquid chromatography-photodiode 
array-atmospheric pressure chemical ionization-tandem 
mass spectrometry 
LDL - low density lipoprotein 
LPL - lipoprotein lipase 
LXR-α - liver X receptor-α 
OGTT - oral glucose tolerance test 
Pi3K - phosphoinositide 3-kinase 
SREBP - sterol regulatory element-binding protein 
T2D - type 2 diabetes 
TL - tube lens 
ZDF - Zucker Diabetic Fatty. 
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Body weight, 24-hour food intake, and whole 
blood glucose collection after overnight-fasting 
were measured weekly throughout the experiment. 
At 15 weeks of age, blood pressure and heart rate 
were measured. OGTT was performed on different 
days. On the third day, the overnight-fasted ani-
mals were anesthetized by intraperitoneal injec-
tion with a lethal dose of sodium pentobarbital, 
and blood was collected by retro-orbital puncture. 
This final sample was also analyzed for FFA. The 
animals were terminated by cervical dislocation. A 
midline laparotomy was performed, and liver, so-
leus muscle, and abdominal adipose tissue were 
dissected and snap-frozen in liquid nitrogen for 
subsequent analysis of real-time quantitative po-
lymerase chain reaction (RT-PCR) and hepatic tri-
acylglycerol. The experiments were performed in 
accordance with the local guidelines, and approved 
by the Danish Animal Experiments Inspectorate 
(No. 2010/561-1805). 
Experimental diets 
The animals were randomly divided into 4 
groups fed the following experimental diets ad libi-
tum: 
 
1. Control diet, consisting of a standard chow 
laboratory animal diet (Altromin 1324, Bro-
gaarden, Denmark). 
2. Bilberry diet, with 15% of the standard chow 
substituted with bilberries. 
3. Blackcurrant diet, with 15% of the standard 
chow substituted with blackcurrants. 
4. Fiber diet. 
 
To incorporate the berries into pellets, bil-
berries and blackcurrants were applied as a whole-
berry product powder (Joswola Oy, Iisalmi, 
Finland). Fresh whole berries originating from 
Finland were gently dried to remove the water 
fraction in a single drying process at approxi-
mately 30°C to reduce the loss of nutrients, and 
were then ground into powder. The mean food in-
take was 33 g per day in both berry groups. Hence, 
the 15% berry enrichment corresponded to 5 g of 
berry powder per day ingested by each animal on 
average (equaling 25 g of fresh berry). 
Macronutrient composition and dietary fiber 
content of the berry powders were analyzed using 
the specific Nordic Committee on Food Analysis. 
The powders were subsequently mixed with stan-
dard chow into pellets by Altromin Spezialfutter 
(GmbH, Lage, Germany). The fiber group was fed 
standard chow with the addition of cellulose and 
pectin prepared by Altromin Spezialfutter (GmbH, 
Lage, Germany), mimicking the fiber content of 
the berry diets, i.e., 9% crude fiber. The energy 
and nutrient composition of the experimental diets 
is presented in Table 1. 
Extraction and analysis of polyphenols 
Berry powder (2.5 g) was extracted with 15 ml 
methanol:water:trifluoroacetic acid (70:30:1, v/v/v) 
for 16 h under constant stirring at 22°C in the 
dark. The extracts were then filtered and collected 
in a 50 ml volumetric flask. The resulting filter 
cake was re-extracted with 15 ml extraction sol-
vent. The volume of the combined extract was ad-
justed to a final volume of 50 ml by 70% aqueous 
methanol and stored at 5°C until analysis. The 
combined extracts were filtered (Whatman Pu-
radisc 13 syringe filters 0.2 µm, Sigma-Aldrich, 
Steinheim, Germany) and put into high-
performance liquid chromatography (HPLC) vials 
before analysis. The extraction procedure resulted 
in the extraction of > 95% of all polyphenols, as 
shown by separate successive extraction experi-
ments (data not shown). All extractions were made 
in three replicates. 
An Agilent 1100 series HPLC system (Agilent 
Technologies, Waldbronn, Germany) equipped 
with a photodiode array detector was used for 
HPLC analysis. Separations of polyphenols were 
performed on a Luna C18(2) 100 Å, end-capped 
(particle size 5 µm; 150 mm × 4.6 mm ID) reversed-
phase column (Phenomenex, Allerød, Denmark). 
The mobile phase consisted of 0.5% trifluoroacetic 
acid in water (solvent A) and 100% acetonitrile 
(solvent B). The following gradient was used: 0 
min (7% B), 60 min (30% B), 65 min (50% B), and 
70 min (7% B). The column temperature was 25°C, 
Table 1. Energy and crude macronutrient composition of the expe-
rimental diets (unit/100 g) fed ad libitum to Zucker Diabetic Fatty 
rats for 8 weeks 
 
 
Component/ 
energy 
 
Experimental diet 
 
  Control     Bilberry  Blackcurrant   Fiber 
 
Protein (g) 19.
 
6 17.
 
4 17
 
.7 19.
 
6 
 
Fat (g) 4.
 
2 4.
 
4 4
 
.6 3.
 
3 
 
Carbohydrate (g) 67.
 
8 70.
 
4 69
 
.1 70.
 
1 
 
Dietary fiber (g) 6.
 
0 8.
 
6 8
 
.9 8.
 
9 
 
Ash (g) 8.
 
3 7.
 
3 7
 
.6 7.
 
0 
 
Energy (kcal) 284
 
 290
 
 286
 
 276
 
 
 
Legend: Values are means. 
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the flow rate was 1 ml/min, the injection volume 
was 10 µl, and the photodiode array detector was 
operated at 280 and 320 nm for phenolic acids, 350 
nm for flavonols, and 520 nm for anthocyanins. 
Phenolic acids, flavonols, and anthocyanins were 
quantified according to a calibration curve of au-
thentic standards of chlorogenic acid (0.007-1.41 
mg/ml), quercetin-3-O-glucoside (0.002-0.47 
mg/ml), and cyanidin-3-O-rutinoside (0.014-1.40 
mg/ml), respectively. 
Furthermore, the molecular weight of the indi-
vidual polyphenols was included in the calcula-
tions of their concentrations, taking into account 
their different molecular weights compared with 
the external standards. Unidentified polyphenols 
were classified as anthocyanins, flavonols, or phe-
nolic acids based on their UV spectra and their 
quantification was based only on calibration 
curves. 
Polyphenols were identified by liquid chroma-
tography-photodiode array-atmospheric pressure 
chemical ionization-tandem mass spectrometry 
(LC-PDA-APCI-MS/MS) [19, 20]. LC-MS data was 
obtained on a LTQ XL mass spectrometer (Linear 
Quadrupole 2D Ion Trap, LTQ20992, Thermo Sci-
entific, San Jose, CA, USA) operated in APCI 
negative mode. Compounds were monitored at 280, 
320, 350, and 520 nm and UV spectra were re-
corded between 200 and 600 nm. Settings for the 
mass spectrometer were 50, 20, and 5 (arbitrary 
units) for sheath, auxiliary, and sweep gas flow 
rates, respectively, with a vaporizer temperature 
of 450°C, a discharge current of 5 µA, and a capil-
lary temperature of 275°C. The settings for the 
capillary voltage (CV) and tube lens (TL) were as 
follows: 
 
- Anthocyanins: CV of -9 V, TL of -85 V 
Table 2. Content of major polyphenols identified in the bilberry (vaccinium myrtillus) and blackcurrant (ribes nigrum) powder included in the 
experimental diets 
 
 
Rt 
 
Polyphenolsa 
 
         Bilberryb
 
  Blackcurrantb 
 
UV-Vis λmax 
(nm) 
 
Characteristic (-)-full scan MS ions 
(m/z) 
  
Total anthocyanins 3441
 
±
 
32 871
 
±
 
13 
 
 
 
 
 
 
 
14.1 
 
   Dephinidin-3-O-galactoside 369
 
±
 
7   
 
524  
 
463 [M-2H]-, 301 
 
15.5 
 
   Delphinidin-3-O-glucoside 348
 
±
 
8 102
 
±
 
2 
 
524  
 
463 [M-2H]-, 301 
 
16.4 
 
   Delphinidin-3-O-rutinoside  326
 
±
 
5 
 
524  
 
609 [M-2H]-, 463, 301 
 
17.0 
 
   Cyanidin-3-O-galactoside 352
 
±
 
5   
 
518  
 
447 [M-2H]-, 285 
 
17.5 
 
   Delphinidin-3-O-arabinoside 338
 
±
 
11   
 
524  
 
433 [M-2H]-, 301 
 
18.5 
 
   Cyanidin-3-O-glucoside 400
 
±
 
11 53
 
±
 
1 
 
518  
 
447 [M-2H]-, 285 
 
19.0 
 
   Petunidin-3-O-galactoside 146
 
±
 
8   
 
528  
 
477 [M-2H]-, 315 
 
19.6 
 
   Cyanidin-3-O-rutinosidec  366
 
±
 
6 
 
518  
 
593 [M-2H]-, 447, 285 
 
20.4 
 
   Cyanidin-3-O-arabinoside 547
 
±
 
6   
 
518  
 
417 [M-2H]-, 285 
 
22.6 
 
   Petunidin-3-O-arabinoside 106
 
±
 
1   
 
528  
 
447 [M-2H]-, 315 
 
23.7 
 
   Peonidin-3-O-glucoside 342
 
±
 
5   
 
521  
 
461 [M-2H]-, 299 
 
25.2 
 
   Malvidin-3-O-glucoside 330
 
±
 
5   
 
528  
 
491 [M-2H]-, 329 
 
27.3 
 
   Malvidin-3-O-arabinoside 93
 
±
 
1   
 
528  
 
461 [M-2H]-, 329 
 
 
 
Total flavonols 84
 
±
 
1 79
 
±
 
1    
 
20.5 
 
   Myricetin hexose-deoxyhexoside  36
 
±
 
1 
 
353  
 
625 [M-H]-, 317 
 
25.0 
 
   Quercetin-3-O-rutinoside  18
 
±
 
1 
 
353  
 
609 [M-H]-, 301 
 
26.0 
 
   Quercetin-3-O-glucosidec 56
 
±
 
1 12
 
±
 
1 
 
353  
 
463 [M-H]-, 301 
 
 
 
Total phenolic acids 255
 
±
 
3 48
 
±
 
1    
 
9.9 
 
   Chlorogenic acidc 101
 
±
 
1   
 
326  
 
353 [M-H]-, 191 
 
 
 
Total polyphenols 3772
 
±
 
33 998
 
±
 
15    
 
Legend: Data are means ± SD. a Identification based on Rt, UV-Vis and LC-MS data compared with data from the literature [19, 20]. 
b Content 
of phenols (mg/100 g powder). c Identified by comparison with an authentic standard. Abbreviations: HPLC - high-performance liquid chroma-
tography. MS - mass spectroscopy. Rt - retention time (min) on HPLC. UV-Vis - ultraviolet and visible light spectroscopy.  
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- Flavonols: CV of -5 V, TL of -80 V 
- Phenolic acids: CV of -9 V, TL of -45 V 
 
Automatic gain control target settings were 3 × 
104 and 1 × 104 for full MS and MS/MS, respec-
tively. Separations were performed at the same 
chromatographic conditions as described above for 
the HPLC analysis. 
Biochemical analyses 
Fasting glucose, HbA1c, FFA, triacylglycerol, 
total cholesterol, and LDL- and HDL-cholesterol, 
obtained at baseline and at the end of the experi-
ment, were determined by a fully automatic Cobas 
c 111 analyzer (Roche Diagnostics GmbH, Mann-
heim, Germany) using colorimetric methods with 
specific kits. The Roche GLUC2 kit was used for 
plasma glucose, the Roche A1c-2 kit including a 
hemolysate application was used for whole blood 
HbA1c and a Wako NEFA-HR2 kit (Wako Chemi-
cals GmbH, Neuss, Germany) was applied for 
plasma FFA. The Roche CHOL2, LDLC, HDLC3, 
and TRIGL kits were used for the analysis of 
plasma total cholesterol, LDL- and HDL-
cholesterol, and triacylglycerol plus hepatic tria-
cylglycerol, respectively. Plasma insulin was de-
termined by radioimmunoassay (RIA) using a sen-
sitive rat insulin RIA kit (Linco Research Inc., St 
Charles, Missouri, USA). All analytic procedures 
were performed in accordance with the manufac-
turers’ instructions. The weekly measurements of 
fasting whole blood glucose were determined by a 
OneTouch glucose monitoring apparatus (Precision 
Xceed, Abbott Laboratories A/S, Denmark). 
Oral glucose tolerance 
test 
Animals were fasted 
overnight (water ad li-
bitum) before the OGTT 
and were given a glu-
cose load of 2.0 g D-
glucose/kg body weight 
as a 60% glucose solu-
tion by gavage. Blood 
samples were drawn 15 
minutes and immedi-
ately before the glucose 
load and after the ga-
vage at 30, 60, 90, 120, 
180, and 240 minutes. 
Whole blood glucose 
was measured from the 
tip of the tail with a 
OneTouch glucose monitoring apparatus (Precision 
Xceed, Abbott Laboratories A/S, Denmark). 
Blood pressure measurements 
At the end of the experiments, systolic blood 
pressure and heart rate were measured in con-
scious, unanesthetized animals by a noninvasive 
tail-cuff method using an automatic computer-
assisted opto-electronic pulse transducer (209000, 
TSE Systems GmbH, Bad Homburg, Germany). 
During the measurements, the animal was held in 
a restrainer under calm conditions. Prior to the 
measurements, the animals had been accustomed 
to the restrainer and to wearing the tail-cuff. To 
achieve adequate blood flow, the tail of the ani-
mals was warmed slightly using an infra-red heat 
lamp. 
RNA isolation and real-time quantitative PCR 
RNA was purified from homogenized liver, 
muscle, and adipose tissue samples by a QIAcube 
(Qiagen, Copenhagen, Denmark) using tissue-
specific RNeasy minikits (Qiagen, Copenhagen, 
Denmark) according to the manufacturer’s instruc-
tions. To examine RNA quantity and quality, opti-
cal density absorbance measurements at 260 and 
280 nm (NanoDrop ND-8000 UV-Vis Spectropho-
tometer, NanoDrop Technologies, Wilmington, 
Germany) and gel electrophoresis of the endoge-
nous controls using a 1% agarose gel electrophore-
sis stained with SYBR green were performed. An 
iScribtTM cDNA synthesis kit (Bio-Rad, Hercules, 
CA, USA) was used to reverse transcribe the puri-
fied RNA to cDNA. 
Table 3. Plasma insulin, glycemic control parameters, blood pressure, and heart rate after 8-week 
treatment with a control, bilberry-, blackcurrant- or fiber-enriched diet 
 
 
Variable 
 
Experimental diet 
 
       Control               Bilberry          Blackcurrant           Fiber 
 
Plasma glucose (mmol/l) 17.
 
9 
 
± 1
 
.8 14.
 
5
 
± 0
 
.9 17.
 
6
 
± 1
 
.8 14.
 
3
 
± 0
 
.9 
 
Plasma insulin (mmol/l) 6.
 
5 
 
± 0
 
.8 8.
 
3
 
± 0
 
.8 5.
 
5
 
± 0
 
.9 7.
 
7
 
± 0
 
.8 
 
HbA1c (%) 5.
 
4 
 
± 0
 
.3 4.
 
7
 
± 0
 
.2 5.
 
3
 
± 0
 
.4 5.
 
0
 
± 0
 
.3 
 
HOMA-IR 119.
 
0 
 
± 14
 
.0 128.
 
0
 
± 11
 
.0 92.
 
0
 
± 10
 
.0 119.
 
0
 
±15
 
.0 
 
HOMA-β (%) 276.
 
0 
 
± 51
 
.0 411.
 
0
 
± 54
 
.0 263.
 
0
 
± 57
 
.0 390.
 
0
 
±54
 
.0 
 
Systolic blood pressure (mmHg) 145.
 
0 
 
± 10
 
.0 151.
 
0
 
± 9
 
.0 151.
 
0
 
± 9
 
.0 157.
 
0
 
±10
 
.0 
 
Heart rate (beats/min) 348.
 
0 
 
± 30
 
.0 379.
 
0
 
± 22
 
.0 357.
 
0
 
± 24
 
.0 344.
 
0
 
±23
 
.0 
 
Legend: Data are means ± SEM, n = 11-12/group. No effect of dietary intervention, one-way 
ANOVA, adjusted for baseline. Abbreviations: HbA1c - glycosylated hemoglobin; HOMA-IR- ho-
meostasis model assessment of insulin resistance; HOMA-β - homeostasis model assessment of β-
cell function (insulin sensitivity). 
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Real-time quantitative PCR was performed by 
the outsourcing company Aros Applied Biotechnol-
ogy A/S (Skejby, Denmark) using the Fluidigm 
BioMark system (Fluidigm 96.96 Dynamic, Flu-
idigm Cat. No. BMK-M-96.96). Gene expression 
was analyzed using rat-specific TaqMan assays 
predesigned by Applied Biosystems with the fol-
lowing assay ID numbers: 
 
- Rn00581185_m1: liver X receptor-α (LXRα) 
- Rn01495769_m1: sterol regulatory element-
binding protein-1c (SREBP1c) 
- Rn01502638_m1: SREBP2 
- Rn00670361_m1: fatty acid binding protein 4 
(FABP4) 
- Rn00561482_m1: lipoprotein lipase (LPL) 
- Rn00595250_m1: adiponectin 
- Rn01483784_m1: adiponectin receptor 1 
(Adipor1) 
- Rn00563565_m1: glucose transporter 2 
(GLUT2) 
- Rn00562597_m1: GLUT4 
- Rn02132493_s1: insulin receptor substrate-1 
(IRS1) 
- Rn01637243_m1: insulin receptor (InsR) 
- Rn00564547_m1: phosphoinositide 3-kinase 
(Pi3K) 
- Rn00690901_m1: serine/threonine-protein 
kinase 2 (Akt2) 
- Rn01473307_m1: c-Jun N-terminal protein 
kinase (JNK-1) 
- Rn01765492_m1: glutamine fructose-6-
phosphate aminotransferase (GFAT) 
 
Two rat-specific assays (S18: ABI, 
Hs99999901_s1 and Hprt1: ABI, Rn01527840_m1) 
were used as endogenous controls. The setup was 
performed in accordance with the manufacturer’s 
protocol in triplicates. One hundred nanograms of 
RNA were used as input in 20-µl reverse transcript 
reactions. The reverse transcription was per-
formed using the high capacity cDNA reverse 
transcription kit (ABI, PN4368813) in accordance 
with manufacturer’s protocol. 
After reverse transcription, the cDNA samples 
were amplified using Fluidigm Specific Target 
Amplification. Briefly, the cDNA was amplified us-
ing a target-specific assay (diluted 1:100) and 
TaqMan PreAmp master mix (2X) (ABI, PN 
4391128) in a 14 cycle thermal cycler reaction: 10 
min at 95°C and 14 cycles of 15 sec at 95°C and 4 
min at 60°C. Amplification was performed using 
the standard conditions: 2 min at 50°C, 10 min at 
95°C and 40 cycles of 15 sec at 95°C and 1 min at 
60°C. Relative quantification of gene expression 
was performed using the 2-∆∆CT (comparative CT) 
method [21] to determine the relative expression. 
Table 4. Relative expression of selected genes involved in lipid and glucose metabolism in Zucker Diabetic Fatty rats after 8-week dietary 
intervention 
 
 
Gene 
 
                                    Experimental diet 
 
         Acronym                       Bilberry                 Blackcurrant                  Fiber 
 
Liver X receptor-α LXRαa 0.
 
76
 
± 0
 
.03*,# 
 
0. 
 
85 
 
± 0
 
.04# 1.
 
20
 
± 0
 
.06* 
 
Sterol regulatory element-binding protein 1c SREBP1ca 0.
 
85
 
± 0
 
.09# 
 
1. 
 
02 
 
± 0
 
.09 1.
 
53
 
± 0
 
.20 
 
Sterol regulatory element-binding protein 2 SREBP2a 0.
 
87
 
± 0
 
.04# 
 
0. 
 
80 
 
± 0
 
.03*,# 1.
 
18
 
± 0
 
.06 
 
Adiponectin receptor 1 AdipoR1a 0.
 
85
 
± 0
 
.04# 
 
0. 
 
94 
 
± 0
 
.04# 1.
 
21
 
± 0
 
.07 
 
Glucose transporter 2 GLUT2a 0.
 
82
 
± 0
 
.03*,# 
 
0. 
 
83 
 
± 0
 
.03*,# 1.
 
16
 
± 0
 
.07 
 
Glucose transporter 4 GLUT4b 1.
 
54
 
± 0
 
.08* 
 
1. 
 
28 
 
± 0
 
.10 1.
 
20
 
± 0
 
.07 
 
Insulin receptor substrate 1 IRS1a 0.
 
81
 
± 0
 
.05*,# 
 
0. 
 
85 
 
± 0
 
.05# 1.
 
02
 
± 0
 
.03 
 
Insulin receptor InsRa 0.
 
91
 
± 0
 
.04# 
 
0. 
 
92 
 
± 0
 
.03# 1.
 
17
 
± 0
 
.05* 
 
Phosphoinositide 3-kinase Pi3Ka 0.
 
88
 
± 0
 
.04# 
 
0. 
 
92 
 
± 0
 
.07# 1.
 
30
 
± 0
 
.10 
 
Serine/threonine-protein kinase 2 Akt2a 0.
 
82
 
± 0
 
.05# 
 
0. 
 
92 
 
± 0
 
.06 1.
 
75
 
± 0
 
.25 
 
C-Jun N-terminal protein kinase JNK-1a 0.
 
83
 
± 0
 
.05*,# 
 
0. 
 
94 
 
± 0
 
.04# 1.
 
36
 
± 0
 
.10 
 
Glutamine fructose-6-phosphate aminotransferase GFATa 0.
 
82
 
± 0
 
.04*,# 
 
0. 
 
82 
 
± 0
 
.04*,# 1.
 
22
 
± 0
 
.07 
 
Legend: Data are means ± SEM, expressed relative to the control diet, n = 11-12/group. Quantitative RT-PCR was performed for the selected 
genes, and was normalized to the geometric mean of two endogenous controls (S18 and Hprt1). a Expressed in hepatic tissue. b Expressed in 
subcutaneous adipose tissue. * p < 0.05 vs. control diet, one-way ANOVA or Kruskal-Wallis’ test. # p < .05 vs. fiber diet, one-way ANOVA or 
Kruskal-Wallis’ test. 
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Statistical analysis and calculations 
Data analysis was performed using Stata sta-
tistical software (version 11.0; StataCorp LP, Col-
lege Station, Texas, USA). The data are expressed 
as the mean ± SEM unless stated otherwise. One-
way analysis of variance (ANOVA) followed by lin-
ear regression analysis was used to compare dif-
ferences among group means. Both tests included 
baseline as covariable. Normal distribution and 
equal variances across groups were tested using 
quantile-quantile plots and Bartlett’s test, respec-
tively. 
Whenever data were not normally distributed 
or when variances differed, data were logarithmi-
cally transformed. If the assumptions were still 
not met, the nonparametric Kruskal-Wallis test 
followed by Dunn’s multiple comparisons test was 
applied. Time by treatment interactions for food 
intake, body weight and fasting whole blood glu-
cose were analyzed using two-way repeated meas-
ures ANOVA. P < 0.05 was considered significant. 
At a statistical power of 80% (p < 0.05), the num-
ber of animals needed per group was 10 to detect a 
difference of 300 ± 130 mmol/l x 240 min (mean ± 
SD) on our primary effect parameter, the incre-
mental area under the glucose curve (iAUC). 
Glucose iAUC measurements obtained at the 
OGTT were calculated using the trapezoidal 
method [22]. The homeostasis model assessment 
equation was used to estimate insulin resistance 
(HOMA-IR) and β-cell function (HOMA-β) based on 
fasting plasma insulin and glucose measurements 
[23]. 
The expression levels of the target genes are 
presented as fold changes relative to the control 
group. False discovery rate correction [24] was 
used to address the problem of multiple statistical 
testing of gene expression to eliminate false posi-
tives. Consequently, only expression values with p-
values below the calculated false discovery rate 
cut-off value are reported as significant. 
Results 
Of the 48 animals entering the experiment, one 
animal in the fiber group died during the OGTT 
procedure performed at the end of trial. Thus, data 
was obtained from only 11 animals for final bio-
chemical analyses and gene expression in the rele-
vant group. 
Polyphenols in bilberry and blackcurrant pow-
ders 
The content of major polyphenols in selected 
phenolic classes (anthocyanins, flavonols, and 
phenolic acids) of the berry powders used in the 
present study is presented in Table 2. Major poly-
phenols constituted approximately 98% of the total 
polyphenol content, of which anthocyanins consti-
tuted 91.2% and 87.3% of the total polyphenol con-
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Figure 1. Effects of 8-week diet treatment of Zucker Diabetic Fatty (ZDF) rats. The diets consisted of a control as well as bil-
berry, blackcurrant, and fiber enrichment. The diagrams show the weekly changes in fasting whole blood glucose (left) and 
incremental area under the curve (iAUC) for plasma glucose (right) measured by oral glucose tolerance test before and after 
intervention. Data are shown as mean ± SEM, n = 11-12/group. * p < 0.05 blackcurrant vs. control and fiber. † p < 0.05 bil-
berry vs. control by two-way repeated measures ANOVA. 
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tent in bilberry and blackcurrant powder, respec-
tively. However, bilberry powder contained 3441 
mg anthocyanins/100 g, which was approximately 
4 times greater than the content identified in the 
blackcurrant powder (871 mg anthocyanins/100 g). 
In total, 11 major anthocyanins were character-
ized and quantified in bilberries, including 3-O-
arabinosides, 3-O-glucosides, and/or 3-O-
galactosides of five anthocyanidins: cyanidin, del-
phinidin, malvidin, peonidin, and petunidin. In 
blackcurrants, only four major anthocyanins with 
aglycones of cyanidin and delphinidin were ob-
served (Table 2). Flavonoids, i.e., flavonols, consti-
tuted only 2.2% and 7.9% of the total polyphenol 
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Figure 2. Effects of 8-week treatment with a control, bilberry-, blackcurrant-, and fiber-enriched diet on plasma and hepatic 
triacylglycerol, plasma total cholesterol, free fatty acids, LDL-cholesterol, and HDL-cholesterol levels in Zucker Diabetic Fatty 
rats. Values are mean ± SEM, n = 11-12/group. One-way ANOVA, adjusted for baseline. * p < 0.05. † p < 0.01 versus control 
diet. 
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content in bilberries and blackcurrants, respec-
tively. Only one major phenolic acid, chlorogenic 
acid, was observed, but only in bilberries (Table 
2). 
Body weight and food intake 
As expected, body weight and food intake in-
creased gradually during the experiment. No dif-
ferences in body weight gain (p = 0.4424) and final 
body weight (control: 452 g ± 46 g, bilberry: 479 g ± 
25 g, blackcurrant: 445 g ± 48 g, fiber: 470 g ± 26 
g; p = 0.1183) were observed between diet groups. 
Likewise, no interaction in food intake between 
time and treatment emerged with the exception of 
11 weeks of age, when the mean intake in the bil-
berry group (31.3 g ± 3.6 g) was lower than in the 
control group (36.8 g ± 4.4 g; p < 0.01) and the fi-
ber group (36.0 g ± 4.1 g; p < 0.05). 
Glucose metabolism 
At baseline, glycemic control and fasting insulin 
did not differ significantly among the diet groups 
(p ≥ 0.1396, data not shown). As illustrated in 
Figure 1, fasting whole blood glucose was signifi-
cantly higher in the blackcurrant group (7.2 
mmol/l) compared with the control group (4.6 
mmol/l, p < 0.05) and the fiber group (4.6 mmol/l, p 
< 0.05) at 10 weeks of age, and significantly lower 
in the bilberry group (6.2 mmol/l) compared with 
the control group (9.0 mmol/l, p < 0.05) at the end 
of trial. 
In contrast, fasting plasma glucose did not dif-
fer among the groups at the end of trial (Table 3, 
p = 0.2346), nor did HbA1c (p = 0.25). Likewise, 
the iAUC0-240min, for glucose (Figure 1) and the in-
crements in fasting insulin (Table 3) were similar 
among the diet groups at the end of the experi-
ment (p = 0.815 and p = 0.24, respectively). Fur-
thermore, HOMA-IR and HOMA-β appeared not to 
be significantly affected by the dietary interven-
tions (p = 0.174, p = 0.135, respectively; Table 3). 
When compared with the control group, the he-
patic mRNA expression of GLUT-2, IRS-1, JNK-1, 
and GFAT were downregulated in the bilberry 
group (20%, p < 0.05; 19% p < 0.01; 17% p < 0.05; 
20% p < 0.05, respectively), and GLUT2 and GFAT 
were downregulated in the blackcurrant group 
(18% and 19%, respectively; p < 0.05 for all) (Ta-
ble 4). Likewise, when compared with the fiber 
group, the hepatic expression of Adipor1, GLUT2, 
IRS1, InsR, Pi3K, JNK-1, and GFAT were down-
regulated in the bilberry group (30%, p < 0.001; 
29%, p < 0.001; 20%, p < 0.01; 22%, p < 0.001; 32%, 
p < 0.001; 39%, p < 0.001; 33%, p < 0.001, respec-
tively) and in the blackcurrant group (22%, p < 
0.01; 28%, p < 0.001; 16%, p < 0.05; 21%, p < 0.001; 
29%, p < 0.01; 31%, p < 0.01; 33%, p < 0.001, re-
spectively) (Table 4). 
In addition, the hepatic expression of Akt2 
(53%, p < 0.01) was downregulated in the bilberry 
versus fiber group. The fiber diet upregulated the 
expression of hepatic InsR compared with the con-
trol diet (16%, p < 0.05; Table 4). In adipose tis-
sue, the expression of GLUT4 was upregulated in 
the bilberry group compared with the control 
group (40%, p < 0.01; Table 4). In muscle tissue, 
gene expression levels were similar between the 
selected genes. Diets did not affect adiponectin dif-
ferently in any of the tissues (data not shown). 
Lipid profile 
As shown in Figure 2, no lipid variables dif-
fered between diet groups at baseline (p ≥ 0.349). 
During the experiments, the mean total cholesterol 
increased in the control and fiber group, whereas 
the levels decreased in the two berry groups. At 
the end of the experiments, total cholesterol was 
significantly lower in the bilberry group compared 
with the control group (-21%, p = 0.003, Figure 2). 
Over time, LDL-cholesterol decreased in the 
bilberry group and increased in the remaining 
groups. Consequently, the bilberry group exhibited 
a significantly lower LDL-cholesterol concentra-
tion at the end of trial compared with the control 
group (-60%, p = 0.004, Figure 1). As can be seen 
in Figure 2, HDL-cholesterol increased in all 
groups. However, at the end of the trial, HDL-
cholesterol had increased significantly more in the 
control group than in the bilberry (26%, p = 0.003) 
and blackcurrant group (18%, P = 0.037). In addi-
tion, HDL-cholesterol tended to increase more in 
the control versus fiber group (16%, p = 0.069). No 
significant differences in plasma FFA (p = 0.6479) 
or in triacylglycerol in either plasma (p = 0.272) or 
liver (p = 0.71) were observed between the dietary 
groups (Figure 2). 
When compared with the control group, hepatic 
mRNA expression of LXR-α was downregulated in 
the bilberry group (24%, p < 0.001), and SREBP-2 
was downregulated in the blackcurrant group 
(22%, p < 0.05) (Table 4). Likewise, when com-
pared with the fiber group, the hepatic expression 
of LXR-α and SREBP2 was decreased in the bil-
berry (36%, p < 0.001; 26%, p < 0.001, respectively) 
and the blackcurrant groups (29%, p < 0.001; 33%, 
p < 0.001, respectively) (Table 4). In addition, the 
hepatic expression of SREBP1c (45%, p < 0.01) was 
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downregulated in the bilberry versus fiber group. 
The group fed a fiber diet exhibited an upregula-
tion of hepatic LXR-α compared with the group fed 
control diet (19%, p < 0.05, Table 4). The diets did 
not differentially affect LPL or FABP4 in any of 
the tissues (data not shown). 
Blood pressure and heart rate 
As shown in Table 3, the animals exhibited an 
elevated systolic blood pressure at the end of the 
trial, i.e., at 15 weeks of age. However, neither sys-
tolic blood pressure (p = 0.842) nor heart rate were 
differentially affected between the diet groups (p = 
0.761). 
Discussion 
To our knowledge, this is the first trial to report 
the effects of bilberries and blackcurrants per se on 
selected CVD risk factors in ZDF rats. The present 
trial demonstrated that a diet enriched with bil-
berries improved lipid profile by reducing total 
cholesterol by 21% and LDL-cholesterol by 60%. 
However, bilberry as well as blackcurrant enrich-
ment resulted in less elevation of HDL-cholesterol 
than the control diet. No impact of diet enrichment 
with bilberries or blackcurrants was detected on 
glucose tolerance, insulin sensitivity or blood pres-
sure. 
The lipid-ameliorating effect of bilberries is an 
appealing finding, as hyperlipidemia, especially 
elevated LDL-cholesterol, is strongly related to the 
development of atherosclerosis [25]. An identical 
effect on total cholesterol has recently been ob-
served in duplicate with an anthocyanin-rich bil-
berry extract given to atherosclerotic (apo E-/-) mice 
for two weeks [26, 27]. Moreover, a reduction in to-
tal cholesterol was observed in diabetic (KK-Ay) 
mice when treated with anthocyanin-rich bilberry 
extract (27 g/kg diet) for 5 weeks [16] and in Fisher 
rats treated with an anthocyanin-rich grape-
bilberry juice for 10 weeks [28]. 
In other trials, the consumption of bilberries as 
either juice, anthocyanin-rich extract or in con-
junction with other kind of berries induced no ef-
fect on total cholesterol [10, 12-15]. In accordance 
with the present findings, Qin et al. reported a 
suppressed LDL-cholesterol response to an extract 
of mixed anthocyanins from bilberry and blackcur-
rant (320 mg/day) given to dyslipidemic subjects 
for 12 weeks [14]. 
Food intake and body weight did not differ be-
tween the diet groups, suggesting that neither of 
these parameters contributed to the suppression of 
total and LDL-cholesterol. Moreover, it seems 
unlikely that the positive effect of bilberry was as-
cribed to its higher content of dietary fiber com-
pared with the control, as both the blackcurrant 
and the fiber group had fiber content comparable 
with bilberry but exhibited no effect on cholesterol 
concentrations. However, the relatively high con-
tent of anthocyanins combined with a more com-
plex anthocyanin composition in bilberries com-
pared with blackcurrants could indicate that an-
thocyanins may play an important role in the ob-
served cholesterol-lowering effect of bilberry. 
The liver is the key organ in maintaining cho-
lesterol homeostasis, and bilberry-extract has re-
cently been suggested to modulate the hepatic ex-
pression of genes involved in cholesterol metabo-
lism [26]. In the present study, the expression of 
LXR-α was downregulated by the bilberry diet 
compared with the control diet (fold change = 
0.76), consistent with the lower cholesterol levels. 
LXR-α promotes the hepatic production of apolipo-
protein B-containing lipoprotein particles [29], and 
synthetic LXR agonists have been shown to in-
crease LDL-cholesterol and apolipoprotein B in 
non-human primates [30]. In addition, LXR-α acti-
vation promotes cholesterol biosynthesis and lipo-
genesis through the regulation of lipogenic master 
genes like SREBP-1c and SREBP2 [31]. However, 
SREBP-1c and SREBP2 mRNA were not down-
regulated to a statistically significant level by bil-
berry treatment (fold change = 0.85 and 0.87, re-
spectively). 
Unexpectedly and contrary to human trials [13, 
14], HDL-cholesterol increased to a lesser extent in 
the bilberry group compared with the control 
group. To our knowledge, no animal trials have re-
ported the effect of bilberries or blackcurrants on 
HDL separately, though two studies in rats have 
reported no effect on the HDL to LDL ratio al-
though the total cholesterol level was reduced [26, 
27]. This conflicting finding may somehow be ex-
plained by the physiological differences that exist 
in human and rodent HDL metabolism. In line 
with this, treatment with fibrates lowers HDL lev-
els in rodents by reducing PPARα activation, 
which decreases the expression of the HDL major 
apolipoprotein, Apo A-I in liver, whereas in hu-
mans, fibrates increase plasma HDL levels via en-
hanced Apo A-I gene expression induced by in-
creased PPARα activation [32, 33]. Mechanisti-
cally, the smaller increase in HDL-cholesterol ob-
served following the berry diets may be explained 
by the downregulation of hepatic LXR-α mRNA, 
given that this nuclear factor activates the tran-
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scription of a spectrum of genes regulating reverse 
cholesterol transport and thereby raises HDL-
cholesterol [34]. 
As for triacylglycerol, similar levels were ob-
served in both the plasma and liver, which cor-
roborates the findings obtained in most [11-15, 27, 
28] but not all trials [16, 26]. Differing effects of 
whole berry powder versus purified berry antho-
cyanins intake may in part explain the conflicting 
findings on triacylglycerol [35]. The lack of differ-
ences in the plasma and hepatic triacylglycerol be-
tween groups corroborates the gene expression 
findings and the comparable findings of plasma in-
sulin and FFA among the diets. 
In general, glucose metabolism was not modi-
fied by bilberry or blackcurrant enrichment of the 
diet, as shown previously [11, 12, 14, 28], but not 
unequivocally [16]. Dietary fructose appears to at-
tenuate hepatic insulin signaling by JNK activa-
tion [36]. Accordingly, one possible explanation for 
the diverging findings could be ascribed to the use 
of berry anthocyanin-rich extracts versus whole 
berry powder because of the amount of fructose 
present in berries [37]. Furthermore, comparing 
the berry diets with a control and fiber diet con-
taining no monosaccharides, as was done in the 
present study, might blur a potential ameliorating 
effect of bilberries and blackcurrants on glucose 
metabolism. 
Fiber-enrichment per se had no beneficial effect 
on glucose metabolism either, which corresponds 
with other rodent trials investigating the effect of 
cellulose, the primary fiber component used in the 
present trial [38, 39]. Skeletal muscle is the pri-
mary site of glucose disposal and therefore is a ma-
jor tissue that contributes to plasma glucose levels. 
Nevertheless, no differences in the expression of 
genes related to glucose metabolism in muscle tis-
sue were observed, mimicking the findings in bio-
chemical glucose parameters. 
Changes in the expression levels of genes re-
lated to glucose metabolism were almost exclu-
sively observed in hepatic tissue, which can partly 
be explained by the tissue distribution of antho-
cyanins. In mice, anthocyanins were detected in 
the liver but not in muscle or white fat tissue after 
the consumption of bilberry extract [40]. It has 
previously been shown that increased GFAT activ-
ity is associated with insulin resistance and post-
prandial hyperglycemia in T2D [41]. In addition, 
hepatic JNK-1 induces insulin resistance by serine 
phosphorylation of IRS1 [42]. Due to reduced 
GFAT and JNK-1 expression induced by bilberry 
intake (fold change = 0.82 and 0.83, respectively), 
hepatic insulin sensitivity may therefore be 
slightly more conserved when adding bilberries to 
the diet, which may also explain the lower fasting 
whole blood glucose level observed at the end of 
the trial and the putative decrease in hepatic oxi-
dative stress [43]. This is further supported by the 
hepatic GLUT2 down-regulation [44]. In contrast, 
expression levels of IRS1 were lowered by bilberry 
intake, suggesting impaired insulin signaling. 
However, the lower transcription of IRS1 could in-
dicate a lower degree of JNK-mediated IRS1 phos-
phorylation as a direct result of the lower JNK-1 
transcription rather than impaired insulin signal-
ing. Moreover, transcriptional changes in adipose 
tissue imply enhanced adipocyte insulin sensitivity 
in the bilberry group, as the expression of GLUT4 
was upregulated [44]. 
At 15 weeks of age, the animals exhibited mild 
hypertension. A modest blood pressure-lowering 
effect of bilberry consumed together with other 
berries has been indicated [13]. However, we did 
not observe differences in the systolic blood pres-
sure between diets, corroborating previous obser-
vations [11, 12, 14]. 
Conclusions 
In conclusion, the present study demonstrated 
that bilberry intake ameliorated total cholesterol 
and LDL-cholesterol levels in ZDF rats, possibly 
by inhibiting hepatic LXR-α gene expression. A 
blunted increase in the HDL-cholesterol level was 
observed in the bilberry- and blackcurrant-
enriched diets compared with the control. In con-
trast to our hypothesis, neither bilberry nor black-
currant enrichment delayed the development of 
T2D or influenced blood pressure differently from 
the control diet. Nevertheless, changes in gene ex-
pression implied less impaired hepatic and adipo-
cyte insulin sensitivity after bilberry supplementa-
tion. 
The results indicate that bilberries, possibly by 
virtue of their relatively high content of antho-
cyanins, may serve as a valuable dietary preventa-
tive agent in hypercholesterolemia. However, cau-
tion should be exercised in the interpretation of 
our results because there are significant differ-
ences in HDL cholesterol metabolism between rats 
and humans. Consequently, further research is 
needed to determine whether the observed effects 
in rats also apply to humans. 
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